Use of adenovirus type-5 vectored vaccines: a cautionary tale

dc.creatorBuchbinder, Susan P.
dc.creatorMcElrath, M. Juliana
dc.creatorDieffenbach, Carl
dc.creatorCorey, Lawrence
dc.date.accessioned2020-10-21T21:06:44Z
dc.date.available2020-10-21T21:06:44Z
dc.date.issued2020
dc.description.abstractIndisponível.pt_BR
dc.identifier.citationBUCHBINDER, S. P. et al. Use of adenovirus type-5 vectored vaccines: a cautionary tale. The Lancet, [S.l.], 2020.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/43533
dc.identifier.urihttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32156-5/fulltextpt_BR
dc.languageen_USpt_BR
dc.rightsopenAccesspt_BR
dc.sourceThe Lancetpt_BR
dc.subjectCOVID-19 - Vaccinept_BR
dc.subjectRecombinant adenovirus type-5 (Ad5)pt_BR
dc.titleUse of adenovirus type-5 vectored vaccines: a cautionary talept_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição: